1 Incredible Reason to Buy Berkshire Hathaway's (BRK.B) Stock in November

Berkshire Hathaway's stock has underperformed the S&P 500, declining over 9% since Warren Buffett announced his planned departure as CEO by end-2025, with Greg Abel succeeding him. Despite investor concerns, the company recently executed a strategic $9.7 billion all-cash acquisition of Occidental's OxyChem business, a move seen as shrewd for its valuation and positive impact on Occidental's debt. Berkshire maintains a substantial cash hoard of nearly $345 billion, and its energy operations are positioned for growth, potentially offering a buying opportunity at current price-to-book levels.

Analysis

Berkshire Hathaway (BRK.A, BRK.B) shares have experienced a significant pullback, declining over 9% since the announcement of Warren Buffett's planned departure as CEO by the end of 2025, leading to underperformance against the S&P 500. This market reaction reflects investor concern over the leadership transition, despite Greg Abel being named as successor and Buffett remaining Chairman.

Despite this sentiment-driven decline, Berkshire's underlying operations remain robust, with operating earnings rising 27% to $47.4 billion in fiscal 2024 and a substantial cash reserve of nearly $345 billion as of Q2. The company recently deployed $9.7 billion in an all-cash acquisition of Occidental's OxyChem business, a strategic move valued at less than 10 times trailing-12-month pre-tax operating income, which is expected to enhance both Berkshire's portfolio and Occidental's financial position.

The current stock valuation, with its price-to-book ratio approaching the three-year average, suggests a potential buying opportunity. Furthermore, Berkshire's energy segment is well-positioned for future growth, particularly from increasing electricity demand driven by artificial intelligence data centers. The upcoming November earnings report will be Buffett's last as CEO, offering further insights into the company's trajectory.

Key Decisions for Investors

• Consider the current stock pullback as a potential long-term entry point, given the attractive price-to-book valuation and underlying operational strength.
• Monitor the upcoming November earnings report for insights into leadership transition and continued business performance.
• Evaluate the strategic benefits of the OxyChem acquisition and the growth potential of Berkshire's energy segment driven by AI demand.